A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
Joyce Lee
Study ID
Protocol Number: 20-0243
More information available at ClinicalTrials.gov: NCT03955146
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers